US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 267 actively recruiting studies with Colorado sites out of 267 registered in total. The busiest research areas in Colorado are Solid Tumor, Ovarian Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include University of Colorado, Denver, Janssen Research & Development, LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (52), Phase 2 (80), Phase 3 (81), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
267
Recruiting Now
267
← Back to US Map
Top Conditions in Colorado
Solid Tumor (6)Ovarian Cancer (5)Acute Myeloid Leukemia (4)Cervical Cancer (4)Breast Cancer (4)Prostate Cancer (4)Heart Failure (4)Pancreatic Ductal Adenocarcinoma (PDAC) (3)Neoplasm Metastasis (3)Endometrial Cancer (3)Melanoma (3)Migraine (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 267 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 267. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Ovarian Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT04963751 N/A
Recruiting
ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling
Condition
Enhanced Recovery After Surgery
Enrollment
60 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
175 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
View Trial →
NCT06919692 N/A
Recruiting
Maternal Left Lateral Position in Fetal Growth Restriction
Condition
Fetal Growth Restriction
Enrollment
100 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT02074839 Phase 1
Recruiting
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malign...
Condition
Relapsed or Refractory Acute Myeloid Leukemia (AML)
Enrollment
291 pts
Location
United States, France
Sponsor
Institut de Recherches Interna
View Trial →
NCT07775495 N/A
Recruiting
Observational Study of Decentralized Urine Optical Interaction Patterns Associat...
Condition
Healthy Adult Participants
Enrollment
15 pts
Location
United States
Sponsor
Ecotera Health LLC
View Trial →
NCT07382167 Phase 3
Recruiting
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopa...
Condition
Chronic Idiopathic Constipation (CIC)
Enrollment
692 pts
Location
United States
Sponsor
Ardelyx
View Trial →
NCT06971939 Phase 4
Recruiting
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Includi...
Condition
Macular Telangiectasia Type 2 (MacTel)
Enrollment
234 pts
Location
United States, Australia
Sponsor
Neurotech Pharmaceuticals
View Trial →
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06548542 Phase 2
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Moderat...
Condition
Crohn's Disease
Enrollment
590 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie
View Trial →
NCT06833073 Phase 2
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Ca...
Condition
Urinary Bladder Neoplasms
Enrollment
308 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05780034 Phase 1
Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Condition
Relapsed/Refractory B-cell Malignancies
Enrollment
60 pts
Location
United States
Sponsor
Accutar Biotechnology Inc
View Trial →
NCT03866382 Phase 2
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) ...
Condition
Bladder Adenocarcinoma
Enrollment
314 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07224373 Phase 1
Recruiting
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Condition
Multiple Sclerosis
Enrollment
24 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
View Trial →
NCT07599670 Phase 1, Phase 2
Recruiting
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or ...
Condition
Alzheimer's Disease
Enrollment
210 pts
Location
United States, China
Sponsor
AbbVie
View Trial →
NCT06026410 Phase 1
Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Condition
Solid Tumors With HRAS Alterations
Enrollment
300 pts
Location
United States, France, Germany
Sponsor
Kura Oncology, Inc.
View Trial →
NCT06373861 N/A
Recruiting
Generating Advancements Through Longitudinal Analysis in X and Y Variations (GAL...
Condition
Sex Chromosome Aneuploidy
Enrollment
5,000 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07669168 N/A
Recruiting
Health Ahead Comparative Effectiveness Study
Condition
Health Services Accessibility
Enrollment
1,000,000 pts
Location
United States
Sponsor
William Brandenburg, MD
View Trial →
Page 11 of 11 — 267 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology